top of page
Clinical trials are crucial to learning. These trials are required for FDA licensing of therapeutic drugs. Field trials that are required by FDA to license treatments are called effectiveness studies.
Any medication provided in a Clinical Trial will have package labeling or package insert labeling that includes contact information to report the response to treatment including side effects. Adverse events or drug related side effects should be brought to the attention of your veterinarian. You may report adverse events directly to Pathogenes by phone or email, Please email supporting information such as examinations by veterinarians, blood analysis, or any treatments that were administered for the abnormal signs.
NeuroQuel Study 219-3.7.1
for the control of clinical signs of polyneuritis equi enrollment is completed! This study is closed and under review.
We will soon have the only licensed treatment for polyneuritis equi (PNE)! The final step is a NeuroQuel full effectiveness study that is intended to show the study medication can alleviate signs of PNE.
PNE is a rare disease. Without your support to license this treatment there will continue to be no treatments available. We will post the inclusion criteria for the full effectiveness trial soon.
bottom of page